Nurix Therapeutics (NRIX) FCF Margin Growth (3y) (2022 - 2026)
Nurix Therapeutics (NRIX) FCF Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | - |
| 2 | Nanobiotix | 1,941.00 Bn | 1,940.94 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.62 Bn | 468.83 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 123.20 Bn | 115.95 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.57 Bn | 51.38 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 6,066.00 |
| 10 | Nurix Therapeutics | 2.65 Bn | 2.21 Bn | - | -101,836.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -101,836.00 |
| Feb 28, 2026 | -77,755.00 |
| Nov 30, 2025 | 10,467.00 |
| Aug 31, 2025 | -24,622.00 |
| May 31, 2025 | 14,319.00 |
| Feb 28, 2025 | 12,925.00 |
| Nov 30, 2024 | 10,420.00 |
| Aug 31, 2024 | -4,341.00 |
| May 31, 2024 | 10,413.00 |
| Feb 29, 2024 | -40,198.00 |
| Nov 30, 2023 | 53,001.00 |
| Aug 31, 2023 | -4,484.00 |
| May 31, 2023 | 31,987.00 |
| Feb 28, 2023 | -181,779.00 |
| Nov 30, 2022 | 17,190.00 |